- Changes in the Eradication Rate of Conventional Triple Therapy for Helicobacter pylori Infection in Korea
-
Heo J, Jeon SW
- KMID: 1730924
- Korean J Gastroenterol.
- 2014 Mar;63(3):141-145.
- doi: 10.4166/kjg.2014.63.3.141
Although, the prevalence of Helicobacter pylori infection in Korea has declined owing to the eradication therapy, recent seroprevalence of H. pylori infection is still reported to be as high as... -
- CITED
-
- Close
- SHARE
-
- Close
- Future Trends of Helicobacter pylori Eradication Therapy in Korea
-
Lee JY, Kim N
- KMID: 1730927
- Korean J Gastroenterol.
- 2014 Mar;63(3):158-170.
- doi: 10.4166/kjg.2014.63.3.158
The prevalence of Helicobacter pylori infection in Korea shows a decreasing trend and has changed to that of developed country, especially for those below 30 years old. However, the primary... -
- CITED
-
- Close
- SHARE
-
- Close
- New Therapeutic Strategies against Helicobacter pylori
-
Kang BK, Park SM, Kim BW
- KMID: 1730925
- Korean J Gastroenterol.
- 2014 Mar;63(3):146-150.
- doi: 10.4166/kjg.2014.63.3.146
The standard therapy for Helicobacter pylori infection in Korea is a triple-drug regimen consisting of a proton pump inhibitor with two antibiotics such as clarithromycin, amoxicillin, and metronidazole. However, as... -
- CITED
-
- Close
- SHARE
-
- Close
- New Guidelines for Helicobacter pylori Treatment: Comparisons between Korea and Japan
-
Lee SY
- KMID: 1730926
- Korean J Gastroenterol.
- 2014 Mar;63(3):151-157.
- doi: 10.4166/kjg.2014.63.3.151
Korea and Japan show the highest incidence of gastric cancer and Helicobacter pylori infection. New 2013 guidelines on H. pylori infection differ between the two countries with regard to the... -
- CITED
-
- Close
- SHARE
-
- Close
